{
    "2021-11-01": [
        [
            {
                "time": "",
                "original_text": "大健康产业发展投资并购动态周报Vol.70",
                "features": {
                    "keywords": [
                        "大健康产业",
                        "投资",
                        "并购"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "业绩更好的复星医药，为什么市值不足恒瑞医药一半？",
                "features": {
                    "keywords": [
                        "复星医药",
                        "恒瑞医药",
                        "市值",
                        "业绩"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药企表现出强劲的研发投入意愿，让研发站上“C”位",
                "features": {
                    "keywords": [
                        "药企",
                        "研发投入",
                        "研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "里昂：重申复星医药(02196)“买入”评级 目标价微升至67.6港元",
                "features": {
                    "keywords": [
                        "里昂",
                        "复星医药",
                        "买入",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "永泰说新闻 | 国家卫健委发布《互联网诊疗监管细则(征求意见稿)》，我国首个《CAR-T细胞产品质量控制要求》已实施",
                "features": {
                    "keywords": [
                        "国家卫健委",
                        "互联网诊疗",
                        "CAR-T",
                        "质量控制"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "政策"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大行评级 | 里昂：复星医药(2196.HK)第三季业绩胜预期 重申“买入”评级",
                "features": {
                    "keywords": [
                        "里昂",
                        "复星医药",
                        "第三季",
                        "业绩",
                        "买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东方证券：给予复星医药增持评级",
                "features": {
                    "keywords": [
                        "东方证券",
                        "复星医药",
                        "增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东方证券给予复星医药增持评级，2021年三季报点评：业绩稳健增长，重磅产品商业化不断推进",
                "features": {
                    "keywords": [
                        "东方证券",
                        "复星医药",
                        "三季报",
                        "业绩",
                        "商业化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}